2,078
Views
6
CrossRef citations to date
0
Altmetric
HPV – Research Paper

AVPCancerFree: Impact of a digital behavior change intervention on parental HPV vaccine –related perceptions and behaviors

, , , , , , , , , , & show all
Article: 2087430 | Received 16 Dec 2021, Accepted 06 Jun 2022, Published online: 14 Jun 2022

References

  • Centers for Disease Control and Prevention. How many cancers are linked with HPV each year? [accessed 2021 Feb 12]. https://www.cdc.gov/cancer/hpv/statistics/cases.html.
  • Drolet M, Benard E, Perez N, Brisson M, Hpvvis G, Boily M-C, Baldo V, Brassard P, Brotherton JML, Callander D. Population-Level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):1–13. doi:10.1016/S0140-6736(19)30298-3.
  • Elam-Evans LD, Yankey D, Singleton JA, Sterrett N, Markowitz LE, Williams CL, Fredua B, McNamara L, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years — United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(33):1109–1116. doi:10.15585/mmwr.mm6933a1.
  • Lei J, Ploner A, Elfstrom KM, Wang J, Roth A, Fang F, Sundström K, Dillner J, Sparén P. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med. 2020;383(14):1340–1348. doi:10.1056/NEJMoa1917338.
  • Hildesheim A, Herrero R, Wacholder S, Rodriguez AC, Solomon D, Bratti MC, Schiller JT, Gonzalez P, Dubin G, Porras C. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007;298(7):743–753. doi:10.1001/jama.298.7.743.
  • Leval A, Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, Young C, Netterlid E, Sparén P, Arnheim-Dahlström L. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst. 2013;105(7):469–474. doi:10.1093/jnci/djt032.
  • Ali H, Guy RJ, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Donovan B. Decline in in-patient treatments of genital warts among young Australians following the national HPV vaccination program. BMC Infect Dis. 2013;13(1):140. doi:10.1186/1471-2334-13-140.
  • Giuliano AR, Lazcano-Ponce E, Villa L, Nolan T, Marchant C, Radley D, Golm G, McCarroll K, Yu J, Esser M. Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine. J Infect Dis. 2007;196(8):1153–1162. doi:10.1086/521679.
  • Smulian EA, Mitchell KR, Stokley, Stokley S. Interventions to increase HPV vaccination coverage: a systematic review. Hum Vaccin Immunother. 2016;12(6):1566–1588. doi:10.1080/21645515.2015.1125055.
  • Khodadadi AB, Redden DT, Scarinci IC. HPV vaccination hesitancy among latina immigrant mothers despite physician recommendation. Ethn Dis. 2020;30(4):661–670. doi:10.18865/ed.30.4.661.
  • Nguyen KH, Santibanez TA, Stokley S, Lindley MC, Fisher A, Kim D, Greby S, Srivastav A, Singleton J. Parental vaccine hesitancy and its association with adolescent HPV vaccination. Vaccine. 2021;39(17):2416–2423. doi:10.1016/j.vaccine.2021.03.048.
  • Tsui J, Vincent A, Anuforo B, Btoush R, Crabtree BF. Understanding primary care physician perspectives on recommending HPV vaccination and addressing vaccine hesitancy. Hum Vaccin Immunother. 2021;17(7):1961–1967. doi:10.1080/21645515.2020.1854603.
  • Vadaparampil ST, Kahn JA, Salmon D, Lee J-H, Quinn GP, Roetzheim R, Bruder K, Malo TL, Proveaux T, Zhao X. Missed clinical opportunities: provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine. 2011;29(47):8634–8641. doi:10.1016/j.vaccine.2011.09.006.
  • Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi PG. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med. 2007;161(3):252–259. doi:10.1001/archpedi.161.3.252.
  • Beavis A, Krakow M, Levinson K, Rositch AF. Reasons for lack of HPV vaccine initiation in NIS-teen over time: shifting the focus from gender and sexuality to necessity and safety. J Adolesc Health. 2018;63(5):652–656. doi:10.1016/j.jadohealth.2018.06.024.
  • Gidengil C, Chen C, Parker AM, Nowak S, Matthews L. Beliefs around childhood vaccines in the United States: a systematic review. Vaccine. 2019;37(45):6793–6802. doi:10.1016/j.vaccine.2019.08.068.
  • Rodriguez SA, Mullen PD, Lopez DM, Savas LS, Fernandez ME. Factors associated with adolescent HPV vaccination in the US: a systematic review of reviews and multilevel framework to inform intervention development. Prev Med. 2020;131:105968. doi:10.1016/j.ypmed.2019.105968.
  • Head KJ, Biederman E, Sturm LA, Zimet GD. A retrospective and prospective look at strategies to increase adolescent HPV vaccine uptake in the United States. Hum Vaccin Immunother. 2018;14(7):1626–1635. doi:10.1080/21645515.2018.1430539.
  • Cataldi JR, O’Leary ST, Markowitz LE, Allison MA, Crane LA, Hurley LP, Brtnikova M, Beaty BL, Gorman C, Meites E. Changes in strength of recommendation and perceived barriers to human papillomavirus vaccination: longitudinal analysis of primary care physicians, 2008-2018. J Pediatr. 2021;234:149–157 e143. doi:10.1016/j.jpeds.2021.03.002.
  • Walker KK, Owens H, Zimet G. “We fear the unknown”: emergence, route and transfer of hesitancy and misinformation among HPV vaccine accepting mothers. Prev Med Rep. 2020;20:101240. doi:10.1016/j.pmedr.2020.101240.
  • Lama Y, Quinn SC, Nan X, Cruz-Cano R. Social media use and human papillomavirus awareness and knowledge among adults with children in the household: examining the role of race, ethnicity, and gender. Hum Vaccin Immunother. 2021;17(4):1014–1024. doi:10.1080/21645515.2020.1824498.
  • Ortiz RR, Smith A, Coyne-Beasley T. A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination. Hum Vaccin Immunother. 2019;15(7–8):1465–1475. doi:10.1080/21645515.2019.1581543.
  • de Cock C, van Velthoven M, Milne-Ives M, Mooney M, Meinert E. Use of apps to promote childhood vaccination: systematic review. JMIR Mhealth Uhealth. 2020;8(5):e17371. doi:10.2196/17371.
  • Texas Department of State Health Services, Texas Health Steps. Adolescent health. A guide for providers. 2011 [accessed 2014 Mar 1].
  • Thompson DM, Fernald DH, Mold JW. Intraclass correlation coefficients typical of cluster-randomized studies: estimates from the Robert Wood Johnson prescription for health projects. Ann Fam Med. 2012;10(3):235–240. doi:10.1370/afm.1347.
  • Dixon BE, Zimet GD, Xiao S, Tu W, Lindsay B, Church A, Downs SM. An educational intervention to improve HPV vaccination: a cluster randomized trial. Pediatrics. 2019;143(1):e20181457. doi:10.1542/peds.2018-1457.
  • Creanor S, Lloyd J, Hillsdon M, Dean S, Green C, Taylor RS, Ryan E, Wyatt K. Detailed statistical analysis plan for a cluster randomised controlled trial of the healthy lifestyles programme (HeLP), a novel school-based intervention to prevent obesity in school children. Trials. 2016;17(1):599. doi:10.1186/s13063-016-1737-y.
  • Hemming K, Marsh J. A menu-driven facility for sample-size calculations in cluster randomized controlled trials. Stata J. 2013;13(1):114–135. doi:10.1177/1536867X1301300109.
  • Becker ERB, Shegog R, Savas SS, Frost EL, Healy CM, Spinner SW, Vernon SW. Informing content and feature design of a parent-focused HPV vaccination digital behavior change intervention: synchronous text-based focus groups. JMIR Formative Res. 2021;5(11):e28846. doi:10.2196/28846.
  • Becker ERB, Myneni S, Shegog R, Fujimoto K, Savas LS, Frost EL, Healy CM, Spinner S, Vernon SW. Parent engagement with a self-tailored cancer prevention digital behavior change intervention: exploratory application of affiliation network analysis. MedInfo. In press.
  • Becker ERB, Shegog R, Savas LS, Frost EL, Coan SP, Healy CM, Spinner SW, Vernon SW. Parents experience with an mHealth intervention to influence HPV vaccination decision-making: mixed methods study. JMIR Pediatr Parent. 2022;5(1):e30340. PMID: 35188469. doi:10.2196/30340.
  • Bartholomew Eldredge LK, Markham CM, Ruiter RAC, Fernandez ME, Kok G, Parcel GS. Planning health promotion programs: an intervention mapping approach. 4th ed. San Francisco (CA): Jossey-Bass; 2016.
  • Hochbaum GM. Public participation in medical screening programs: a socio-psychological study. Washington (DC): U.S. Department of Health, Education, and Welfare; 1958.
  • Bandura A. Human agency in social cognitive theory. Am Psychol. 1989;44(9):1175–1184. doi:10.1037/0003-066X.44.9.1175.
  • Fishbein M. A reasoned action approach to health promotion. Med Decis Making. 2008;28(6):834–844. doi:10.1177/0272989X08326092.
  • Perez S, Tatar O, Ostini R, Shapiro GK, Waller J, Zimet G, Rosberger Z. Extending and validating a human papillomavirus (HPV) knowledge measure in a national sample of Canadian parents of boys. Prev Med. 2016;91:43–49. doi:10.1016/j.ypmed.2016.07.017.
  • McRee AL, Brewer NT, Reiter PL, Gottlieb SL, Smith JS. The Carolina HPV immunization attitudes and beliefs scale (CHIAS): scale development and associations with intentions to vaccinate. Sex Transm Dis. 2010;37(4):234–239. doi:10.1097/OLQ.0b013e3181c37e15.
  • Reiter PL, Brewer NT, Gottlieb SL, McRee AL, Smith JS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Soc Sci Med. 2009;69(3):475–480. doi:10.1016/j.socscimed.2009.05.024.
  • Dempsey AF, Butchart A, Singer D, Clark S, Davis M. Factors associated with parental intentions for male human papillomavirus vaccination: results of a national survey. Sex Transm Dis. 2011;38(8):769–776. doi:10.1097/OLQ.0b013e318211c248.
  • Vernon SW, Savas LS, Shegog R, Healy CM, Frost EL, Coan SP, Gabay EK, Preston SM, Crawford CA, Spinner SW. Increasing HPV vaccination in a network of pediatric clinics using a multi-component approach. J Appl Res Child. 2019;10(2):8. PMC7416872.
  • Stata Statistical Software: Release 16 [ computer program]. College Station (TX): StataCorp LP; 2019.
  • Goesling B. A practical guide to cluster randomized trials in school health research. J Sch Health. 2019;89(11):916–925. doi:10.1111/josh.12826.
  • Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York (NY): John Wiley & Sons, Inc.; 2000.
  • Crawford CA, Shegog R, Savas LS, Frost EL, Healy CM, Coan SP, Gabay EK, Spinner SW, Vernon SW. Using intervention mapping to develop an efficacious multicomponent systems-based intervention to increase human papillomavirus (HPV) vaccination in a large urban pediatric clinic network. J Appl Res Children Informing Policy Children Risk. 2020;10(2):Article 9. PMCID: 7386427.
  • Krebs P, Duncan DT. Health app use among US mobile phone owners: a national survey. JMIR Mhealth Uhealth. 2015;3(4):e101. doi:10.2196/mhealth.4924.
  • Du J, Preston SM, Sun H, Shegog R, Cunningham RM, Boom JA, Savas LS, Amith M, Tao C. Utilizing machine learning-based approaches for the detection and classification of human papillomavirus (HPV) vaccine misinformation: infodemiology study of reddit discussions. JMIR. 2021;23(8):e26478.
  • Nurzhynska A. Pros and cons of chatbot counselling for vaccine hesitancy. [accessed 2021 May 13]. https://www.comminit.com/content/pros-and-cons-chatbot-counselling-vaccine-hesitancy.
  • Ferrand J, Hockensmith R, Houghton RF, Walsh-Buhi ER. Evaluating smart assistant responses for accuracy and misinformation regarding human papillomavirus vaccination: content analysis study. J Med Internet Res. 2020;22(8):e19018. doi:10.2196/19018.